Lotus Pharmaceutical Co Ltd 1795
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 261.00
- Day Range
- TWD 257.50–262.00
- 52-Week Range
- TWD 205.00–347.00
- Bid/Ask
- TWD 258.00 / TWD 258.50
- Market Cap
- TWD 68.38 Bil
- Volume/Avg
- 859,237 / 2.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.38
- Price/Sales
- 4.00
- Dividend Yield (Trailing)
- 1.80%
- Dividend Yield (Forward)
- 1.80%
- Total Yield
- 1.80%
Company Profile
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. The only reportable segment of the company is the Pharmaceuticals business segment, which engages mainly in the research and development, manufacturing and sales of pharmaceutical products. It has its geographic presence in United States, South Korea, Taiwan and Others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,099
- Website
- https://www.lotuspharm.com.tw
Comparables
Valuation
|
Metric
|
1795
|
1799
|
1701
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.38 | — | 17.90 |
Price/Book Value | 3.70 | 17.53 | 0.85 |
Price/Sales | 4.00 | 34.76 | 0.71 |
Price/Cash Flow | 12.66 | — | 9.37 |
Price/Earnings
1795
1799
1701
Financial Strength
|
Metric
|
1795
|
1799
|
1701
|
|---|---|---|---|
Quick Ratio | 1.51 | 2.89 | 0.78 |
Current Ratio | 2.16 | 4.02 | 1.47 |
Interest Coverage | 9.51 | −7.48 | 7.82 |
Quick Ratio
1795
1799
1701
Profitability
|
Metric
|
1795
|
1799
|
1701
|
|---|---|---|---|
Return on Assets (Normalized) | 11.31% | −13.15% | 2.79% |
Return on Equity (Normalized) | 22.12% | −24.34% | 4.78% |
Return on Invested Capital (Normalized) | 14.71% | −13.95% | 3.69% |
Return on Assets
1795
1799
1701
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hldwxxxhp | Nbb | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Xvbxbwmy | Hpknbz | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Vqnrjfcl | Jsw | $45.9 Bil | |||
| Viatris Inc
VTRS
| Swvzczygd | Lnv | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Xlzjhbfl | Kxhmk | $13.2 Bil | |||
| Catalent Inc
CTLT
| Mjhbdhkqz | Mgdqj | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Rppnzrk | Hmpjgt | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Kdhzxskt | Fkl | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Xpzmrzsmk | Nvbwq | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Qcmgdgt | Qmf | $2.2 Bil |
United States